UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 27, 2005
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware (State or Other Jurisdiction of Incorporation) |
1-4389 (Commission File No.) |
06-1534213 (IRS Employer Identification No.) |
301 Merritt 7
Norwalk, Connecticut 06851
(Address of Principal Executive Offices, Including Zip Code)
(203) 840-2000
(Registrant’s
telephone number, including area code)
Item 2.02. Results of Operations and Financial Condition.
Item 9.01. Financial Statements and Exhibits.
The following exhibits are filed with this Report:
Exhibit No. | Description | ||
99.1 | Press Release issued January 27, 2005, with respect to financial results for Applera and Applera’s Applied Biosystems Group. | ||
99.2 | Press Release issued January 27, 2005, with respect to financial results for Applera and Applera’s Celera Genomics Group. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By: | /s/ Dennis L. Winger | |
Dennis L. Winger Senior Vice President and Chief Financial Officer |
||
Dated: January 27, 2005
EXHIBIT INDEX
Exhibit No. | Description | ||
99.1 | Press Release issued January 27, 2005, with respect to financial results for Applera and Applera’s Applied Biosystems Group. | ||
99.2 | Press Release issued January 27, 2005, with respect to financial results for Applera and Applera’s Celera Genomics Group. |